Jill Marie Broadfoot

ATYR

Jill Marie Broadfoot serves as officer: Chief Financial Officer at aTyr Pharma, Inc. (ATYR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$21.9K

Total Sells

5 trades

$14.2K

Net Position

Net Buyer

$7.8K

Companies Traded

ATYR

Active Period

Jan 2022 – Feb 2026

7 total trades

Most Recent

Sell ATYR

Feb 4, 2026 · $1.5K

Jill Marie Broadfoot's Insider Trading at aTyr Pharma, Inc. (ATYR)

Buys

2 · $21.9K

Sells

5 · $14.2K

Total Shares Bought

6,923

Total Shares Sold

7,526

ATYR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 4, 2026	Sell	1,558	$0.98	$1.5K	37,296
Feb 3, 2026	Sell	1,558	$0.98	$1.5K	0
Feb 3, 2025	Sell	1,254	$3.78	$4.7K	0
May 31, 2024	Buy	5,000	$1.79	$8.9K	0
Feb 5, 2024	Sell	1,590	$1.69	$2.7K	0
Feb 3, 2023	Sell	1,566	$2.36	$3.7K	0
Jan 13, 2022	Buy	1,923	$6.75	$13.0K	0

Related Insiders

DENYES NANCY

officer: General Counsel

ATYRSell · Feb 4, 2026

Sanjay Shukla

President and CEO

ATYRSell · Feb 4, 2026

SCHIMMEL PAUL

Director

ATYRBuy · Oct 8, 2025

Explore More Insider Trading Data

ATYR Insider Trading Activity

View all insider trades at aTyr Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity